Work

FLT3 D835 mutations confer differential resistance to type II FLT3 inhibitors

Year: 2015

Type: article

Source: Leukemia

DOI: 10.1038/leu.2015.165

Authors: C C Smith, K Lin, A Stecula, A Sali, N P Shah

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, QB3

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of General Medical Sciences

Awards: Investigating Resistance to FLT3 Inhibitors in AML, G8497617912, Pharmaceutical Sciences and Pharmacogenomics, Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML

OpenAlex ID: W1503281372

FWCI: 9.457

Cites: 17

Cited by: 204

Related to: 10